Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

272.94
Delayed Data
As of May 24
 +8.09 / +3.05%
Today’s Change
242.07
Today|||52-Week Range
420.99
-10.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line924.8M1.0B828.7M969.2M
 
 
 
 
 
Depreciation144.6M151.6M156.3M149.7M
 
 
 
 
 
Total Other Cash Flow68.7M75.2M80.5M25.1M
 
 
 
 
 
Funds From Operations1.0B1.2B1.1B1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-16.5M255.7M65.3M189.5M
 
 
 
 
 
Net Cash Flow - Operating Activities1.0B895.4M1.0B963.4M
 
 
 
 
 
 
InvestingIncrease In Investments-1.7B-2.8B-2.0B-1.9B
 
 
 
 
 
Decrease In Investments602.0M2.4B699.6M1.2B
 
 
 
 
 
Capital Expenditures-129.9M-229.2M-186.1M-126.9M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-2.0K0.00
 
 
Other Investing - Uses-3.4M-323.5M-326.3M-343.0M
 
 
 
 
 
Net Cash Flow Investing-1.3B-989.9M-1.8B-1.2B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings-----436.0K--
 
 
Long Term Debt Reduction-----17.0K--
 
 
Net Proceeds Stock Sale9.1M10.8M8.7M14.5M
 
 
 
 
 
Common Preferred Redeemed-42.2M-3.0B-2.0B0.00
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing18.3M-13.9M7.4M32.9M
 
 
 
 
 
Other Uses - Financing-11.3M62.1M12.3M0.00
 
 
 
 
Net Cash Flow - Financing-3.5M2.9B-2.0B47.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash13.7M-6.2M-15.4M15.1M
 
 
 
 
 
 
Net Change In Cash-209.7M2.8B-2.8B-192.4M